Joel Greenblatt's ANIP Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 8,588 shares of ANI Pharmaceuticals, Inc. (ANIP) worth $786,661, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in ANIP, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2015, adding 34,594 shares. Largest reduction occurred in Q2 2015, reducing 25,621 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's ANI Pharmaceuticals (ANIP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ANI Pharmaceuticals (ANIP) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +4,085 | New Buy | 4,085 | $56.30 |
| Q1 2015 | +34,594 | Add 846.85% | 38,679 | $62.54 |
| Q2 2015 | -25,621 | Reduce 66.24% | 13,058 | $62.03 |
| Q3 2015 | +11,743 | Add 89.93% | 24,801 | $39.51 |
| Q4 2015 | -24,801 | Sold Out | 24,801 | $0.00 |
| Q1 2016 | +11,688 | New Buy | 11,688 | $33.62 |
| Q2 2016 | -4,364 | Reduce 37.34% | 7,324 | $55.84 |
| Q3 2016 | -2,561 | Reduce 34.97% | 4,763 | $66.34 |
| Q4 2016 | -626 | Reduce 13.14% | 4,137 | $60.67 |
| Q1 2017 | -4,137 | Sold Out | 4,137 | $0.00 |
| Q2 2018 | +15,962 | New Buy | 15,962 | $66.78 |
| Q3 2018 | -1,511 | Reduce 9.47% | 14,451 | $56.54 |
| Q4 2018 | -14,451 | Sold Out | 14,451 | $0.00 |
| Q3 2023 | +5,104 | New Buy | 5,104 | $58.06 |
| Q4 2023 | +4,165 | Add 81.60% | 9,269 | $55.14 |
| Q1 2024 | -1,519 | Reduce 16.39% | 7,750 | $69.13 |
| Q2 2024 | -2,821 | Reduce 36.40% | 4,929 | $63.68 |
| Q3 2024 | -4,929 | Sold Out | 4,929 | $0.00 |
| Q3 2025 | +8,588 | New Buy | 8,588 | $91.60 |
Joel Greenblatt's ANI Pharmaceuticals Investment FAQs
Joel Greenblatt first purchased ANI Pharmaceuticals, Inc. (ANIP) in Q4 2014, acquiring 4,085 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held ANI Pharmaceuticals, Inc. (ANIP) for 44 quarters since Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to ANI Pharmaceuticals, Inc. (ANIP) was in Q1 2015, adding 38,679 shares worth $2.42 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 8,588 shares of ANI Pharmaceuticals, Inc. (ANIP), valued at approximately $786,661. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ANI Pharmaceuticals, Inc. (ANIP) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in ANI Pharmaceuticals, Inc. (ANIP) was 38,679 shares, as reported at the end of Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.